Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.50 |
| ▸ | CYP2A6 | P11509 | 4/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.50 |
| ▸ | TSHR | P16473 | 3/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | HPRT1 | P00492 | 1/20 | 0.46 |
| ▸ | MAOA | P21397 | 1/20 | 0.46 |
| ▸ | MAOB | P27338 | 1/20 | 0.46 |
| ▸ | CYP1B1 | Q16678 | 5/20 | 0.42 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.41 |
| ▸ | POLB | P06746 | 2/20 | 0.41 |
| ▸ | ESR1 | P03372 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 5/20 | 0.41 |
| ▸ | CYP1A1 | P04798 | 4/20 | 0.41 |
| ▸ | ABCG2 | Q9UNQ0 | 2/20 | 0.41 |
| ▸ | PDE5A | O76074 | 1/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29853219 | 1.00 | ALDH1A1 (0.50) | ALDH1A1CYP2A6HSD17B10TSHRTDP1 | |
| SCHEMBL29837225 | 0.89 | HPRT1 (0.58) | ALDH1A1CYP2A6HSD17B10TSHRTDP1 | |
| SCHEMBL15511404 | 0.89 | HPRT1 (0.58) | ALDH1A1CYP2A6HSD17B10TSHRTDP1 | |
| SCHEMBL31011152 | 0.89 | HPRT1 (0.58) | ALDH1A1CYP2A6HSD17B10TSHRTDP1 | |
| SCHEMBL20873440 | 0.89 | HPRT1 (0.58) | ALDH1A1CYP2A6HSD17B10TSHRTDP1 | |
| SCHEMBL4111060 | 0.86 | ALDH1A1 (0.45) | ALDH1A1CYP2A6HSD17B10TSHRTDP1 | |
| SCHEMBL18740448 | 0.85 | HSD17B10 (0.44) | ALDH1A1CYP2A6HSD17B10TSHRTDP1 | |
| SCHEMBL28975020 | 0.84 | CYP1A2 (0.43) | ALDH1A1CYP2A6HSD17B10TSHRTDP1 | |
| SCHEMBL14358959 | 0.80 | MAOA (0.46) | ALDH1A1CYP2A6HSD17B10TSHRTDP1 | |
| SCHEMBL29265552 | 0.80 | HPRT1 (0.52) | ALDH1A1CYP2A6HSD17B10TSHRTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 76 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230373929-A1 | FUSED RING DIIMIDE DERIVATIVE, PREPARATION METHOD AND USE THEREOF | XIANGBEI WELMAN PHARMACEUTICAL CO., LTD. (CN) | 2023-11-23 | — | — | US | claimed |
| EP-4215521-A1 | FUSED RING DIIMIDE DERIVATIVE, PREPARATION METHOD THEREFOR AND USE THEREOF | Xiangbei Welman Pharmaceutical Co., Ltd (CN) | 2023-07-26 | — | — | EP | claimed |
| US-20220259493-A1 | SOLAR WAVELENGTH CONVERSION MATERIAL, SOLAR CELL ENCAPSULANT COMPRISING SAME, AND SOLAR CELL COMPRISING SAME | HANWHA TOTALENERGIES PETROCHEMICAL CO., LTD. (KR) | 2022-08-18 | — | — | US | claimed |
| WO-2022073445-A1 | FUSED RING DIIMIDE DERIVATIVE, PREPARATION METHOD THEREFOR AND USE THEREOF | 广州新创意生物医药有限公司 | 2022-04-14 | — | — | WO | claimed |
| CN-103764140-B | Indanone derivatives, pharmaceutically acceptable salts or optical isomers thereof, preparation method for same, and pharmaceutical compositions containing same as active ingredient for preventing or treating viral diseases | 韩国化学研究院 | 2017-05-17 | — | — | CN | claimed |
| CN-1168725-A | Novel photochromic indeno fused naphthopyrans | PPG INDUSTRIES INC (US) | 1997-12-24 | — | — | CN | claimed |
| US-12558341-B2 | Oral complement factor D inhibitors | BIOCRYST PHARMACEUTICALS, INC. (US) | 2026-02-24 | — | — | US | disclosed |
| US-20250186391-A1 | ORAL COMPLEMENT FACTOR D INHIBITORS | WILMINGTON TRUST, NATIONAL ASSOCIATION | 2025-06-12 | — | — | US | disclosed |
| US-11829036-B2 | Optically anisotropic multilayer product and method for producing same | ZEON CORPORATION (JP) | 2023-11-28 | — | — | US | disclosed |
| CN-117119865-A | Light emitting element, electronic device including the same, and electronic apparatus including the same | 三星显示有限公司 | 2023-11-24 | — | — | CN | disclosed |
| US-20230373929-A1 | FUSED RING DIIMIDE DERIVATIVE, PREPARATION METHOD AND USE THEREOF | XIANGBEI WELMAN PHARMACEUTICAL CO., LTD. (CN) | 2023-11-23 | — | — | US | disclosed |
| EP-3668948-B1 | POLYMERISABLE LIQUID CRYSTAL MATERIAL AND POLYMERISED LIQUID CRYSTAL FILM | MERCK PATENT GMBH (DE) | 2023-10-25 | — | — | EP | disclosed |
| EP-3668947-B1 | POLYMERISABLE LC MEDIUM AND POLYMER FILM WITH FLAT OPTICAL DISPERSION | MERCK PATENT GMBH (DE) | 2023-09-27 | — | — | EP | disclosed |
| US-20120129105-A1 | PHOTOSENSITIVE COPOLYMER AND PHOTORESIST COMPOSITION | ROHM AND HAAS ELECTRONIC MATERIALS LLC (US) | 2012-05-24 | — | — | US | disclosed |
| US-20120129105-A1 | PHOTOSENSITIVE COPOLYMER AND PHOTORESIST COMPOSITION | ROHM AND HAAS ELECTRONIC MATERIALS LLC (US) | 2012-05-24 | — | — | US | disclosed |
| EP-2455812-A2 | Photosensitive copolymer and photoresist composition | Rohm and Haas Electronic Materials LLC (US) | 2012-05-23 | — | — | EP | disclosed |
| CN-102448945-A | Anthracene derivative and organic electroluminescent element using the same | IDEMITSU KOSAN CO | 2012-05-09 | — | — | CN | disclosed |
| CN-1168725-A | Novel photochromic indeno fused naphthopyrans | PPG INDUSTRIES INC (US) | 1997-12-24 | — | — | CN | disclosed |
| US-5244917-A | Antiallergens | THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) | 1993-09-14 | — | — | US | disclosed |
| US-4470990-A | 6,7,8,9-Tetrahydronaphtho(1,2-B)furan-8-amine derivatives and their use as dopamine receptor stimulants | AYERST, MCKENNA & HARRISON INC. (CA) | 1984-09-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12558341-B2 | Oral complement factor D inhibitors | CFD, CFH, CFB | ALDH1A1 2667/4885CYP2A6 1256/4885HSD17B10 1149/4885 |
| US-20230373929-A1 | FUSED RING DIIMIDE DERIVATIVE, PREPARATION METHOD AND USE THEREOF | WEE1, CYP51A1, WEE2 | ALDH1A1 612/4885CYP2A6 1574/4885HSD17B10 1243/4885 |
| US-20250186391-A1 | ORAL COMPLEMENT FACTOR D INHIBITORS | CFD, CFH, CFB | ALDH1A1 3142/4885CYP2A6 1436/4885HSD17B10 2891/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.